Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ganmaoan
- Development stage
- Unknown
- Lead developer
- Changhai Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ganmaoan (also referred to as Ganmao'an) is a combination pharmaceutical product widely utilized in China for the treatment of the common cold and upper respiratory tract infections. Typically formulated as granules, it integrates Western active pharmaceutical ingredients with Traditional Chinese Medicine (TCM) herbal extracts. The standard formulation includes paracetamol (acetaminophen) for its analgesic and antipyretic properties, chlorpheniramine maleate as an antihistamine to alleviate nasal symptoms, and caffeine, alongside botanical extracts such as *Isatis tinctoria* (Banlangen), *Lonicera japonica* (Jinyinhua), and *Chrysanthemum indicum* (Yejuhua). Ganmaoan has been the subject of clinical investigation, notably by The First Affiliated Hospital of Naval Medical University, to evaluate its efficacy in managing clinical symptoms in patients with non-severe COVID-19, specifically those infected with the Omicron variant.
- Brand names
- Ganmaoan
- Other names
- Ganmao'anGanmaoan GranulesGanmao'an Granules
02
Targets
HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on ganmaoan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ganmaoan.